Consumer Medicine Information (CMI) summary
The
full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor or pharmacist.
WARNING: Important safety information is provided in a boxed warning in the
full CMI. Read before using this medicine.
1. Why am I using Lenalidomide Viatris?
Lenalidomide Viatris contains the active ingredient lenalidomide. It is used to treat
patients with Multiple Myeloma, Myelodysplastic Syndromes and Mantle Cell Lymphoma.
For more information, see Section
1. Why am I using Lenalidomide Viatris? in the full CMI.
2. What should I know before I use Lenalidomide Viatris?
Do not use if you have ever had an allergic reaction to Lenalidomide Viatris or any
of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section
2. What should I know before I use Lenalidomide Viatris? in the full CMI.
3. What if I am taking other medicines?
4. How do I use Lenalidomide Viatris?
Lenalidomide Viatris should be taken either one hour before or two hours after eating
food. Swallow the capsules whole, preferably with water, once a day as directed by
your doctor. More instructions can be found in Section
4. How do I use Lenalidomide Viatris? in the full CMI.
5. What should I know while using Lenalidomide Viatris?
|
Things you should do
|
All patients: Remind any doctor, dentist or pharmacist you visit you are using Lenalidomide
Viatris.
Female patients: Tell your doctor immediately if you become pregnant or suspect that
you may be pregnant. You should also immediately stop taking Lenalidomide Viatris
in this case.
|
|
Things you should not do
|
Do not stop taking this medicine or change the dose without checking with your doctor.
Female patients: Do not become pregnant whilst taking Lenalidomide Viatris. Do not
have sexual intercourse without using reliable contraception for 4 weeks before starting
treatment, during and after stopping treatment.
Male patients: Do not donate sperm during treatment or treatment interruption, or
for at least 1 week after stopping treatment. Do not have sexual intercourse without
using barrier contraception (e.g. condoms) during treatment and for at least 1 week
after stopping treatment.
|
|
Driving or using machines
|
Lenalidomide Viatris may cause dizziness, tiredness or blurred vision in some people.
If you have any of these symptoms, do not drive, operate machinery or do anything
else that could be dangerous.
|
|
Drinking alcohol
|
Tell your doctor if you drink alcohol.
|
|
Looking after your medicine
|
Keep your capsules in a cool dry place where the temperature stays below 25°C.
Keep your capsules in the original package until it is time to take them.
|
6. Are there any side effects?
Seek immediate medical attention if you experience any difficulty in breathing or
swallowing, swelling of the face, lips, mouth, throat or tongue and unexplained muscle
aches not caused by exercise. For more information, including what to do if you have
any side effects, see Section
6. Are there any side effects? in the full CMI.
|
WARNING: Lenalidomide Viatris (lenalidomide) is structurally related to 'thalidomide',
which is known to cause severe life-threatening human birth defects (deformed babies)
and death to an unborn baby if taken during pregnancy. If Lenalidomide Viatris is
taken during pregnancy, it may cause birth defects or death to an unborn baby. Do
not take Lenalidomide Viatris if you are pregnant or think that you are pregnant.
|
Active ingredient(s):
lenalidomide
Full Consumer Medicine Information (CMI)
This leaflet provides important information about using Lenalidomide Viatris. You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using Lenalidomide Viatris.
Where to find information in this leaflet:
1. Why am I using Lenalidomide Viatris?
Lenalidomide Viatris contains the active ingredient lenalidomide. Lenalidomide Viatris belongs to a group of medicines called immunomodulating agents
that work by acting on the cells involved in the body's immune system. The immune
system is part of the body's defence which helps to fight illness and infection.
Treatment of Multiple Myeloma
Lenalidomide Viatris is used to treat patients with Multiple Myeloma.
Multiple myeloma (MM) is a cancer of the bone marrow.
Treatment of Myelodysplastic Syndromes
Lenalidomide Viatris is used to treat patients who have conditions called myelodysplastic
syndromes (MDS) in whom the bone marrow does not produce enough mature blood cells.
This causes a lack of healthy blood cells in the body. There are different types of
MDS. Lenalidomide Viatris is approved to treat a type of MDS where part of chromosome
5 is missing. This type of MDS is known as deletion 5q MDS (or 5q minus). Patients
with this type of MDS often have low red blood cell counts that require treatment
with blood transfusions. It is hoped that the use of Lenalidomide Viatris will reduce
the need for blood transfusions.
Treatment of Mantle Cell Lymphoma
Lenalidomide Viatris is used to treat adult patients who have been diagnosed with
and previously treated for Mantle Cell Lymphoma (MCL).
MCL is a cancer of the lymph tissue (part of the immune system), affecting a type
of white blood cell called 'B-lymphocytes'. MCL is a disease where B-cells grow in
an uncontrolled way and accumulate in the lymph tissue, bone marrow or blood.
Ask your doctor if you have any questions about how Lenalidomide Viatris works, or
why this medicine has been prescribed for you.
Your doctor may have prescribed it for another reason.
This medicine is not addictive.
Lenalidomide Viatris will only be prescribed to you by a doctor who has experience
in medicines to treat cancers of the blood.
2. What should I know before I use Lenalidomide Viatris?
Warnings
Do not use Lenalidomide Viatris if:
you are allergic to lenalidomide, or any of the ingredients listed at the end of this
leaflet. Some of the symptoms of an allergic response may include:
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body
rash, itching or hives on the skin.
Always check the ingredients to make sure you can use this medicine.
Pregnancy and breastfeeding
Do not use Lenalidomide Viatris if:
you are pregnant or think that you are pregnant. Lenalidomide Viatris may cause birth
defects (deformed babies) and may affect your developing baby if you take it during
pregnancy.
you are able to become pregnant, unless you are willing to follow the required pregnancy
prevention measures (outlined in the pregnancy prevention Program - see section 'Before
you start to take it').
Discuss with your doctor if you should breast-feed whilst taking this medicine.
It is not known if Lenalidomide Viatris is excreted in human milk. Therefore, you
should discuss with your doctor whether to discontinue breast-feeding while you are
receiving this medicine.
Check with your doctor if you:
have or have had any other medical conditions:
Heart attack, blood clots, high blood pressure or high cholesterol
Frequent bleeding or bruising
Frequent infections
Hepatitis B virus infection
Peripheral neuropathy (numbness, tingling, weakness, abnormal coordination or pain
in your hands and feet)
Thyroid problems
Abnormal kidney function
Liver problems e.g. liver infections
Allergic reactions to thalidomide or lenalidomide.
If you have not told your doctor about any of the above, tell him/ her before you
start taking Lenalidomide Viatris.
take any medicines for any other condition
you are pregnant or think that you are pregnant
Please read the Consumer Medicine Information leaflets of any medicines to be taken
in combination with Lenalidomide Viatris before starting treatment with Lenalidomide
Viatris.
If you are not sure whether you should start taking this medicine, talk to your doctor.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section
6. Are there any side effects?
PREGNANCY PREVENTION PROGRAM
Lenalidomide Viatris (lenalidomide) is structurally related to 'thalidomide', which
is known to cause severe life-threatening human birth defects (deformed babies) and
can cause death to an unborn baby if taken during pregnancy. If Lenalidomide Viatris
is taken during pregnancy, it may cause birth defects or death to an unborn baby.
To avoid exposure to unborn babies, Lenalidomide Viatris is available only under a
special distribution and pregnancy prevention Program. This program is designed to
ensure that this medicine is always prescribed and taken in the recommended way.
Importantly, only patients who are formally enrolled in this program and agree to
fully comply with all the requirements of this program can receive Lenalidomide Viatris.
Some of the requirements of Program are outlined in the following sections. Your doctor
will discuss all the details with you.
For women taking Lenalidomide Viatris
Before starting this treatment, your doctor will discuss your potential to become
pregnant, even if you think this is unlikely e.g. if your periods have stopped.
If you are able to become pregnant:
Your doctor will discuss the potential risk to unborn babies if Lenalidomide Viatris
is taken during pregnancy.
You will be required to have pregnancy tests before treatment, every 4 weeks during
treatment, and 4 weeks after stopping treatment.
You should start your Lenalidomide Viatris treatment as soon as you get it from the
pharmacy following a negative pregnancy test.
Use reliable means of contraception for at least 4 weeks before starting Lenalidomide
Viatris treatment, during treatment and treatment interruption, and for at least 4
weeks after Lenalidomide Viatris treatment has stopped.
Your doctor will tell you what method of contraception to use.
Effective methods of contraception include the following:
Implant
Levonorgestrel-releasing intrauterine system (IUS)
Medroxyprogesterone acetate depot
Tubal sterilisation
Sexual intercourse with a vasectomised male partner only; vasectomy must be confirmed
by two negative semen analyses
Ovulation inhibitory progesterone-only pills (i.e. desogestrel).
Combined oral contraceptive pills are not recommended as they can increase the risk
of blood clots blocking blood vessels in patients with MM being treated with this
medicine.
You must stop taking Lenalidomide Viatris and inform your doctor straight away if:
You miss or think you have missed a period, or you have unusual menstrual bleeding,
or suspect you are pregnant.
You have heterosexual intercourse without using reliable means of contraception.
For men taking Lenalidomide Viatris
Before starting this treatment, discuss with your doctor if your partner is able to
become pregnant.
If your partner is able to become pregnant, use barrier methods of contraception (e.g.
condoms) even if you are vasectomised, during Lenalidomide Viatris treatment, during
treatment interruption, and for at least 1 week after treatment has stopped.
Tell your doctor immediately if your partner becomes pregnant whilst you are taking
this medicine.
Do not donate semen during treatment or during treatment interruption, or for 1 week
after stopping treatment.
For all patients taking Lenalidomide Viatris
Do not donate blood during Lenalidomide Viatris treatment or during treatment interruption,
and for at least 1 week after stopping treatment.
In Australia, patients with certain cancers are permanently excluded from donating
blood.
Tell your doctor if you have allergies to any other medicines, foods, preservatives,
or dyes.
Your doctor will ask you to have regular blood tests during treatment with Lenalidomide
Viatris.
Your doctor may adjust your dose of Lenalidomide Viatris or stop your treatment based
on the results of your blood tests and on your general condition. If you are older
than 65 years, in addition to these blood tests, your doctor may also check your kidney
function with other tests.
Do not give this medicine to a child or adolescent under the age of 18 years.
Safety and effectiveness in children younger than 18 years have not been established.
It is important to note that a small number of patients with MM may develop additional
types of cancer (regardless of their type of therapy).
At this stage, it cannot be excluded that this risk may be slightly increased with
Lenalidomide Viatris treatment.
Therefore, your doctor will carefully evaluate the benefit and risk when you are prescribed
this medicine.
3. What if I am taking other medicines?
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Some medicines may interfere with Lenalidomide Viatris and affect how it works.
These include:
medicines used to prevent pregnancy, such as oral contraceptives
medicines used to treat symptoms of menopause e.g. hormone replacement therapy
medicines used for heart problems e.g. digoxin
medicines used to thin the blood e.g. warfarin.
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins
or supplements you are taking and if these affect Lenalidomide Viatris.
4. How do I use Lenalidomide Viatris?
How much to take
Your doctor will tell you how much Lenalidomide Viatris to take and for how long you
will need to take it.
For treatment of NDMM in combination with bortezomib and dexamethasone, the usual
starting dose of Lenalidomide Viatris is 25 mg once daily. Your doctor will tell you
if you are to take Lenalidomide Viatris for 14 continuous days of a 21-Day cycle or
for 21 continuous days of a 28-Day cycle. Your doctor will also tell you the duration
and the quantity of the other medicines to be taken in combination with Lenalidomide
Viatris. After the initial treatment of about 24 weeks, you may have a stem cell transplant,
or your doctor may ask you to take 25 mg of Lenalidomide Viatris once daily for 21
days of a 28-Day cycle continuously.
For the treatment of NDMM after a stem cell transplant, the usual starting dose is
10 mg once daily continuously (28 days of a 28-Day cycle).
For the treatment of MM in combination with dexamethasone (either NDMM in patients
not eligible for stem cell transplantation or MM in patients whose disease has progressed
after one therapy), the usual starting dose is 25 mg once a day for 21 days of a 28-Day
cycle.
For the treatment of MDS, the recommended starting dose is 10 mg once a day for 21
days of a 28-Day cycle.
For the treatment for MCL, the usual starting dose is 25 mg once a day for 21 days
of a 28-Day cycle.
Follow the instructions provided and use Lenalidomide Viatris until your doctor tells
you to stop.
Your doctor will monitor your progress, and may adjust your dose of Lenalidomide Viatris
or stop your treatment based on the results of your blood tests and on your general
condition.
When to take Lenalidomide Viatris
Lenalidomide Viatris should be taken either one hour before or two hours after eating
food.
How to take Lenalidomide Viatris
Swallow the capsules whole, preferably with water, once a day as directed by your
doctor.
Do not open, break or chew the capsules.
If powder from inside the capsules leaks out and contacts the skin, wash the skin
immediately and thoroughly with soap and water. If lenalidomide contacts the mucous
membranes e.g. the eyes, flush thoroughly with water.
If you forget to take Lenalidomide Viatris
Lenalidomide Viatris should be used regularly at the same time each day.
If you miss your dose at the usual time and if it is less than 12 hours before your
next dose, skip the dose you missed and take your next dose when you are meant to.
Otherwise, take it as soon as you remember, and then go back to taking your medicine
as you would normally.
Do not take a double dose to make up for the dose you missed.
If you are not sure what to do, ask your doctor or pharmacist.
If you have trouble remembering when to take your medicine, ask your pharmacist for
some hints.
If you use too much Lenalidomide Viatris
If you think that you have used too much Lenalidomide Viatris, you may need urgent
medical attention.
You should immediately:
phone the Poisons Information Centre
(Australia telephone 13 11 26 or New Zealand telephone 0800 POISON or 0800 764 766) for advice,
contact your doctor, or
go to the Emergency Department at your nearest hospital.
You should do this even if there are no signs of discomfort or poisoning.
5. What should I know while using Lenalidomide Viatris?
Things you should do
FEMALE PATIENTS:
Tell your doctor immediately if you become pregnant or suspect that you may be pregnant.
You should also immediately stop taking Lenalidomide Viatris in this case.
ALL PATIENTS:
Remind any doctor, dentist or pharmacist you visit that you are using Lenalidomide
Viatris.
If you are about to be started on any new medicine, remind your doctor, dentist or
pharmacist that you are taking Lenalidomide Viatris.
Keep all of your doctor's appointments so that your progress can be checked.
Your doctor will do some blood tests regularly and will check your general condition
to make sure the medicine is working and to prevent unwanted side effects.
Things you should not do
FEMALE PATIENTS:
Do not become pregnant whilst taking Lenalidomide Viatris.
Do not have sexual intercourse without using effective means of contraception described
to you by your doctor.
MALE PATIENTS:
Do not donate sperm during treatment or treatment interruption, or for at least 1
week after stopping treatment.
Lenalidomide Viatris can pass into human semen.
Do not have sexual intercourse without using effective means of contraception described
to you by your doctor.
ALL PATIENTS:
Do not donate blood during treatment or treatment interruption, or for at least 1
week after stopping treatment.
In Australia, patients with some types of cancer are permanently excluded from donating
blood.
Do not stop taking Lenalidomide Viatris (unless you suspect that you are pregnant)
or change the dose without first checking with your doctor.
Do not let yourself run out of medicine over the weekend or on holidays.
Do not give this medicine to anyone else, even if they have the same condition as
you.
Do not take this medicine to treat any other complaints unless your doctor tells you
to.
Do not take this medicine after the expiry date printed on the pack or if the packaging
is torn or shows signs of tampering.
In that case, return it to your pharmacist.
Driving or using machines
Be careful before you drive or use any machines or tools until you know how Lenalidomide
Viatris affects you.
Lenalidomide Viatris may cause dizziness, tiredness or blurred vision in some people.
If you have any of these symptoms, do not drive, operate machinery or do anything
else that could be dangerous.
Drinking alcohol
Tell your doctor if you drink alcohol.
Looking after your medicine
Keep your capsules in a cool dry place where the temperature stays below 25°C.
Keep your capsules in the original package until it is time to take them.
Follow the instructions in the carton on how to take care of your medicine properly.
Store it in a cool dry place away from moisture, heat or sunlight; for example, do
not store it:
in the bathroom or near a sink, or
in the car or on window sills.
Keep it where young children cannot reach it.
A locked cupboard at least one-and a-half metres above the ground is a good place
to store medicines.
Getting rid of any unwanted medicine
If you no longer need to use this medicine or it is out of date, take it to any pharmacy
for safe disposal.
Medicines should not be disposed of via wastewater or household waste. These measures
will help to protect the environment.
Do not use this medicine after the expiry date.
6. Are there any side effects?
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your doctor or pharmacist if you
have any further questions about side effects.
Less serious side effects
Serious side effects
|
Serious side effects
|
What to do
|
|
Heart palpitations or fast heart beat, chest pains, dizziness or
fainting, shortness of breath, weakness or reduced ability to exercise.
These could be symptoms of atrial fibrillation (irregular heartbeat) or tachycardia
(fast heartbeat).
Bleeding (including nosebleeds) or bruising more easily than normal.
Lenalidomide Viatris can reduce the number of platelets, which are responsible for
making the blood clot properly. Your doctor may monitor your blood cell numbers during
treatment with Lenalidomide Viatris.
Tiredness, headaches, shortness of breath, dizziness and looking pale.
Lenalidomide Viatris can reduce the number of red blood cells that carry oxygen around
the body.
Numbness, tingling, pins and needles or weakness of the arms and legs.
This may be due to nerve damage.
Blurred vision or difficulty seeing.
This could be due to a cataract in your eye(s).
Passing large amounts of urine, excessive thirst, and having a dry mouth and skin.
These could be symptoms of high blood sugar or diabetes.
Abnormal eye movements, convulsions, mood changes or irregular heart rhythms.
These could be due to low levels of minerals such as potassium, calcium, magnesium
or sodium.
Tender swollen lymph nodes, low-grade fever, pain, or rash.
This could be due to worsening of your tumour (for patients with MCL).
|
Call your doctor straight away or go straight to the Emergency Department at your
nearest hospital if you notice any of these serious side effects.
|
Very serious side effects
|
Very Serious side effects
|
What to do
|
|
Shortness of breath, wheezing or difficulty breathing; swelling of the face, lips,
mouth, tongue or other parts of the body; rash, itching or hives on the skin.
These could be symptoms of an allergic reaction.
Severe blisters and bleeding in the lips, eyes, mouth, nose and genitals; painful
red area on the skin that spreads quickly; peeling of the skin. You may have a high
temperature, chills and muscle ache at the same time.
These could be due to rare but severe skin reactions such as Stevens-Johnson Syndrome,
Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms.
Blurred vision; severe headache; weakness or numbness in the face, arm or leg; trouble
speaking or understanding; loss of balance.
This may be due to a stroke which could be a result of blood clots in the blood vessels
of your brain.
Sudden pain in your chest or difficulty in breathing.
This may be due to a heart attack or blood clots in the artery leading to your lungs.
These blood clots can happen during treatment, or after treatment has stopped.
Chest pain, severe weakness, rapid or irregular heartbeat, and/or sudden, severe shortness
of breath and coughing up pink, foamy mucus.
This could be due to heart failure, a condition where the heart muscle cannot pump
blood strongly enough to supply blood throughout the body.
Pain or swelling in your legs, especially in your lower leg or calves.
This may be due to blood clots in the veins of your leg. These can happen during treatment,
or after treatment has stopped.
Fever; severe chills; decreased urination; rapid pulse; rapid breathing; confusion;
nausea; vomiting; diarrhoea; pain or burning when you urinate; hacking cough; phlegm;
sore mouth or throat; flu-like symptoms; feeling of tension in the nose, cheeks and
behind your eyes; or mouth ulcers.
These could be symptoms of sepsis (blood infection) or other serious infections such
as pneumonia.
Passing little or no urine; drowsiness; nausea; vomiting; or breathlessness.
These could be symptoms of kidney disease.
Abdominal pain, dark urine, fever, joint pain, loss of appetite, nausea and vomiting,
yellowing of the skin and/or eyes.
These are symptoms of liver failure, which in some cases, may be due to Hepatitis
B virus infection. Some cases of Hepatitis B virus infection may not result in symptoms
initially.
|
Stop taking Lenalidomide Viatris and see a doctor immediately or go to the Emergency
Department at your nearest hospital if you notice any of the following very serious
side effects. You may need urgent medical attention or hospitalisation.
|
Tell your doctor or pharmacist if you notice anything else that may be making you
feel unwell.
Other side effects not listed here may occur in some people.
Some side effects (for example, changes in thyroid function, or blood pressure) can
only be found when your doctor does tests from time to time to check your progress.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems.
By reporting side effects, you can help provide more information on the safety of
this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop
taking any of your medicines.
7. Product details
This medicine is only available with a doctor's prescription.
What Lenalidomide Viatris contains
|
Active ingredient
(main ingredient)
|
Lenalidomide Viatris 5 mg -
5 mg Lenalidomide
Lenalidomide Viatris 10 mg -
10 mg Lenalidomide
Lenalidomide Viatris 15 mg -
15 mg Lenalidomide
Lenalidomide Viatris 25 mg -
25 mg Lenalidomide
|
|
Other ingredients
(inactive ingredients)
|
pregelatinised starch
microcrystalline cellulose
croscarmellose sodium
colloidal anhydrous silica
sodium stearyl fumarate
Empty hard gelatin capsule, size ‘2’ (ARTG No.: 140238) (5 mg only)
Empty hard gelatin capsule, size ‘0’ (ARTG No.: 140229) (10 mg only)
Empty hard gelatin capsule, size ‘0’ (ARTG No.: 140230) (15 mg only)
Empty hard gelatin capsule, size ‘0’ (ARTG No.: 140234) (25 mg only)
TekPrintTM SW-9008 Black Ink or TekPrintTM SW-9009 Black Ink (5 mg, 10 mg, 25 mg only)
Opacode® S-1-15094 Red Ink or Opacode® S-1-15095 Red Ink (15 mg only)
|
|
Potential allergens
|
Contains Sulfites
|
Do not take this medicine if you are allergic to any of these ingredients.
What Lenalidomide Viatris looks like
Lenalidomide Viatris capsules are available in 4 different strengths:
Lenalidomide Viatris 5 mg: A No.2, white opaque cap and white opaque body, hard-shell
gelatin capsule filled with white to off-white powder. The capsule is axially printed
with MYLAN over LL 5 in black ink on both cap and body (AUST R 377103). Lenalidomide
Viatris capsules are available in blister packs of 21 capsules.
Lenalidomide Viatris 10 mg: A No.0, green opaque cap and light grey opaque body, hard-shell
gelatin capsule filled with white to off-white powder. The capsule is axially printed
with MYLAN over LL 10 in black ink on both cap and body (AUST R 377099). Lenalidomide
Viatris capsules are available in blister packs of 21 capsules.
Lenalidomide Viatris 15 mg: A No.0, white opaque cap and white opaque body, hard-shell
gelatin capsule filled with white to off-white powder. The capsule is axially printed
with MYLAN over LL 15 in red ink on both cap and body (AUST R 377096). Lenalidomide
Viatris capsules are available in blister packs of 21 capsules.
Lenalidomide Viatris 25 mg: A No.0, white opaque cap and white opaque body, hard-shell
gelatin capsule filled with white to off-white powder. The capsule is axially printed
with MYLAN over LL 25 in black ink on both cap and body (AUST R 377092). Lenalidomide
Viatris capsules are available in blister packs of 21 capsules.
Who distributes Lenalidomide Viatris
Alphapharm Pty Ltd trading as Viatris
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
Phone: 1800 274 276
This leaflet was prepared in April 2024.
Lenalidomide Viatris_cmi\Apr24/00